← SynDRA
CERIVASTATIN
SynDRA canonical compound SYN0007682 — structure-anchored drug synonym record
| Approval status | Approved · OTC |
| Primary target(s) | HMGCR |
| Mechanism of action | HMGCR inhibitor |
All known targets
Mechanisms of action (all sources)
- HMGCR INHIBITOR
- HMG-CoA reductase inhibitor
- HMGCR COMPETITIVE
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ABCB1
- LCK
- NPY1R
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- KDR
- NR3C1
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- GMNN
- NPY2R
- OPRD1
- FLT1
- OPRK1
- TDP1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLCO2B1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- IFNG
- NSD2
- NR1I2
- LRC26
- KSYK
- KCMB4
- KCMB2
- KCMB1
- KCMA1
- GLI3
- CASP3
- GCR
- ESRRA
- CP3A7
- CP3A4
- CP2C9
- CP1A2
- CP19A
- CASP7
- SYK
Drug classes
- Anticholesteremic Agents
- Antimetabolites
- Enzyme Inhibitors
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hypolipidemic Agents
- Lipid Regulating Agents
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
Cross-references
Synonyms
- BAYCOL
- baycol
- baychol
- cerivastatin sodium
- cerivastatin sodium salt hydrate
- Cerivastatine
- Cerivastatina
- Lipobay
- Baycol
- cerivastatin acid
- Cerivastatin [INN:BAN]
- UNII-AM91H2KS67
- CHEBI:3558
- AM91H2KS67
- HSDB 7357
- Statins
- cerivastatinum
- RefChem:575215
- DTXCID402786
- C10AA06
- Cerivastatin (INN)
- CERIVASTATIN [INN]
- rel-Cerivastatin
- CERIVASTATIN [MI]
- CERIVASTATIN [HSDB]
- CERIVASTATIN [VANDF]
- SCHEMBL16346
- BIDD:GT0367
- CERIVASTATIN [WHO-DD]
- GTPL2950
- orb1707467
- SCHEMBL29379484
- BDBM18376
- CHEBI:94755
- SEERZIQQUAZTOL-ANMDKAQQSA-N
- GLXC-20188
- HMS2089B11
- EBC-27153
Look up CERIVASTATIN in the interactive SynDRA portal →